Since July 23, nine listed companies on the science and Technology Innovation Board announced the reduction of their holdings. As of Fridays closing, there were also many announcements of reduction of shares of companies on the science and technology innovation board. Among them, the upper limit of the proposed reduction proportion of Tianyi Shangjias two shareholders is as high as 11.3%.
In the first anniversary of the listing of the science and technology innovation board, the share prices of many listed companies have risen sharply. According to the data, there are 40 listed companies listed on the science and technology innovation board before November 2019. As of July 24, the latest closing price has risen compared with the issuance price, of which 31 stocks have increased by more than 50%, accounting for 77.5%; the stock price increases of half of the stocks since their listing have exceeded 100%.
Since the cost of shares obtained by shareholders before the companys initial listing is very low, almost negligible. After the relevant stocks have gone through a big rise, these original shareholders have a very high proportion of floating profit and will have a very strong desire to reduce their holdings. Therefore, it is expected that in the future, there will probably be more shareholders of listed companies on the science and technology innovation board to join the ranks of reducing their holdings.
Generally speaking, the shareholders announcement of the reduction plan will have a negative impact on the share price of listed companies, especially those with a large proportion of reduction.
Among them, rongbai technology, which owns 0.51% of the shares of Lixin poly enterprise, has announced in the evening of July 23 that several shareholders intend to reduce their shares by no more than 11.95%. The next day, the share price of rongbai technology fell by 8.22%.
Nanwei medicine held by Panfeng value, Tianzhun technology held by Boyi selection and Fuguang shares held by Xinan xinmeihui have all passed the one-year lifting period, but there is no announcement on the reduction plan.
Among the three stocks mentioned above, the stock price of Nanwei Medical Co., Ltd. has been fluctuating and rising since its listing. On July 10, this year, it once touched 253.86 yuan / share. Although it has dropped recently, the closing price as of July 24 still reached 211.26 yuan / share, up 304.99% compared with the issuance price. As of July 24, the latest closing prices of Fuguang shares and Tianzhun technology increased by 58.21% and 7.64% respectively compared with their respective issuance prices.
However, it should be noted that a long time has passed since the first quarter registration, and the positions of the above-mentioned private placements are likely to have changed. Therefore, it is difficult to determine whether it will be affected by the wave of reduction in the scientific and technological innovation board.